TipRanks
pc:excel

Excellergy

10 E Allen St Winooski, Vermont 05404, US
https://www.excelergy.com/
Excellergy is a biotechnology company focused on developing a pioneering portfolio of trifunctional effector cell response inhibitors (ECRIs) to address severe allergic diseases. By utilizing clinically validated Immunoglobulin E (IgE) biology and innovative ECRI pharmacology, Excellergy aims to surpass traditional anti-IgE therapies by directly targeting the source of allergic signaling—IgE bound to effector cells. Headquartered in Palo Alto, California, the company is committed to advancing the standard of care in allergy treatment and improving patient quality of life.

Leadership & Board

Current Number of Employees26
Current LinkedIn Followers481

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$70M
Total Amount Raised$70M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$70M
Latest Funding Amount$70M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Employee Trend

Excellergy had 26 employees as of September 14, 2026. The number of employees increased by 0 (0.00%) week-over-week.
26Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Excellergy had 481 followers as of September 14, 2026. The number of followers increased by 0 (0.00%) week-over-week.
481Latest Followers Count
0(0.00%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 13, 2025
Series A
$70.00M

Investors

Investor Name
Funding Round

Similar Companies

A snapshot of private companies similar to Excellergy, helping you discover and navigate related company profiles.

Related News and Analysis